Lv5
1300 积分 2021-11-12 加入
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial
2天前
已完结
Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study
12天前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
12天前
已完结
Construction and Evaluation of a Nomogram for Unplanned Readmission Within 1 Year After Kidney Transplantation: Based on Lasso-Logistic Regression Model
2个月前
已完结
An immunogenetic basis for lung cancer risk
5个月前
已完结
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
5个月前
已完结
An FGFR inhibitor converts the tumor promoting effect of TGF-β by the induction of fibroblast-associated genes of hepatoma cells
5个月前
已关闭
The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes
5个月前
已完结
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
6个月前
已完结
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
7个月前
已完结
皖公网安备34019202002308
